Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George F Vande Woude

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Suppression of met expression: a possible cancer treatment. Commentary re: S. J. Kim et al., reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clin. Cancer Res., 14: 5161-5170, 2003Nariyoshi Shinomiya, George F Vande Woude
Advances in Cancer Research|July 16, 2008
Advances in Cancer Research: Centennial Volume. IntroductionGeorge Klein, George F Vande Woude
Cell Research|February 3, 2005
HGF/SF-Met signaling in tumor progressionChong Feng Gao, George F Vande Woude
Cell Cycle (Georgetown, Tex.)|March 14, 2007
Mig-6, signal transduction, stress response and cancerYu-Wen Zhang, George F Vande Woude
Nature|April 27, 2002
Developmental biology: an arresting activityNicholas S Duesbery, George F Vande Woude
Journal of Cellular Biochemistry|January 10, 2003
HGF/SF-met signaling in the control of branching morphogenesis and invasionYu-Wen Zhang, George F Vande Woude
Cancer Research|August 15, 2009
The decline in U.S. cancer mortality in people born since 1925Eric J Kort, Nigel Paneth, George F Vande Woude
Cold Spring Harbor Perspectives in Biology|July 3, 2013
MET: a critical player in tumorigenesis and therapeutic targetCarrie R Graveel, David Tolbert, George F Vande Woude
Future Oncology (London, England)|November 15, 2012
RTK inhibition: looking for the right pathways toward a miracleQian Xie, George F Vande Woude, Michael E Berens
Cell Cycle (Georgetown, Tex.)|March 2, 2005
A mouse model of activating Met mutationsCarrie R Graveel, Cheryl A London, George F Vande Woude
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Suppression of met expression: a possible cancer treatment. Commentary re: S. J. Kim et al., reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model. Clin. Cancer Res., 14: 5161-5170, 2003Nariyoshi Shinomiya, George F Vande Woude
Advances in Cancer Research|July 16, 2008
Advances in Cancer Research: Centennial Volume. IntroductionGeorge Klein, George F Vande Woude
Cell Research|February 3, 2005
HGF/SF-Met signaling in tumor progressionChong Feng Gao, George F Vande Woude
Cell Cycle (Georgetown, Tex.)|March 14, 2007
Mig-6, signal transduction, stress response and cancerYu-Wen Zhang, George F Vande Woude
Nature|April 27, 2002
Developmental biology: an arresting activityNicholas S Duesbery, George F Vande Woude
Journal of Cellular Biochemistry|January 10, 2003
HGF/SF-met signaling in the control of branching morphogenesis and invasionYu-Wen Zhang, George F Vande Woude
Cancer Research|August 15, 2009
The decline in U.S. cancer mortality in people born since 1925Eric J Kort, Nigel Paneth, George F Vande Woude
Cold Spring Harbor Perspectives in Biology|July 3, 2013
MET: a critical player in tumorigenesis and therapeutic targetCarrie R Graveel, David Tolbert, George F Vande Woude
Future Oncology (London, England)|November 15, 2012
RTK inhibition: looking for the right pathways toward a miracleQian Xie, George F Vande Woude, Michael E Berens
Cell Cycle (Georgetown, Tex.)|March 2, 2005
A mouse model of activating Met mutationsCarrie R Graveel, Cheryl A London, George F Vande Woude
Pageof 7